Hair Science Medical Hairloss News providing sound Hairloss Options

Reducing the risk of Prostate cancer with Hairscience Hairloss formula
If you have read previous Hair Science Hair loss articles you would now understand that 90% of world wide male hair loss is due to the build up of DHT in the follicle, causing hair miniaturisation.

The anatomy of the male reproductive system works as Testosterone in males is produced primarily in the testicles. The majority of testosterone in the body is bound to sex hormone-binding globulin (SHBG), a protein produced in the liver that
transports testosterone in the bloodstream, prevents its metabolism, and prolongs its half-life. Once it becomes unbound from SHBG, free testosterone can enter cells throughout the body. In certain tissues, the most notable ones being the scalp, skin, epididymis and prostate, testosterone is converted into dihydrotestosterone (DHT) by the enzyme 5-alpha reductase. DHT is a more powerful androgen than testosterone (as it has a much higher affinity for the androgen receptor), so, by converting testosterone to DHT, 5-alpha reductase amplifies the androgenic effect of testosterone in the tissues in which it is found.

In Hairscience's formula an active ingredient is Finasteride, this is a competitive inhibitor of the enzyme 5 beta reductase type 2.

Finasteride is an inhibitor of 5-alpha reductase. By blocking this enzyme, finasteride blocks the conversion of testosterone into the more powerful androgen DHT.

This reduces androgenic activity in the scalp, treating hair loss at its hormonal source. Hairscience also notes hitting 2 birds with the one stone, " control your hairloss and reduce risk of prostate cancer" the prostate, inhibition of 5-alpha
reductase leads to a reduction of prostate volume, which improves the symptoms of benign prostatic hyperplasia (BPH) and reduces the risk of.